Eli Lilly: A Managerial Strategic Audit

Authors

Colby Marsden, University of Nebraska-LincolnFollow
Ethan Domsch, University of Nebraska-LincolnFollow
Whitney Schwisow, University of Nebraska-LincolnFollow
Ryan Marlatt, University of Nebraska-LincolnFollow
Luke Buettner, University of Nebraska-LincolnFollow

Document Type

Thesis

Date of this Version

4-2024

Citation

Schwisow, W., Marsden, C., Domsch, E., Marlatt, R., & Buettner, L. "Eli Lilly: A Managerial Strategic Audit." Undergraduate Honors Thesis, University of Nebraska-Lincoln, 2024.

Comments

Copyright Luke Buettner, Ethan Domsch, Colby Marsden, Ryan Marlatt, Whitney Schwisow 2024.

Abstract

This strategic audit assesses both internal and external landscapes affecting Eli Lilly; financial, qualitative, and competitive performance; strategy and governance; and recent strategic decisions. All information has been gathered from news reports, industry analyst reports, and Lilly’s investor reports, financial statements, and notes to investors. The purpose of this strategic audit is to showcase Lilly’s success in the brand name pharmaceutical industry based on the strategic decisions made in its 147 year history.